Eyestem Research announces Rs 130 Cr investment in Karnataka to advance affordable cell therapies

Bengaluru-based startup Eyestem Research, one of India’s foremost regenerative medicine companies, has announced a major expansion in Karnataka through a Rs 130 crore investment, formalised via a Letter of Intent (LoI) signed with the Government of Karnataka during the Bengaluru Tech Summit (BTS) 2025.